Cost-effectiveness of Barostim therapy for the treatment of resistant hypertension in European settings.

Oleg Borisenko, Joachim Beige, Eric G Lovett, Uta Hoppe (Co-author), Staffan Bjessmo

Research output: Contribution to journalOriginal Articlepeer-review

18 Citations (Web of Science)
Original languageEnglish
Pages (from-to)681-692
JournalJOURNAL OF HYPERTENSION
Volume32
Issue number3
DOIs
Publication statusPublished - 2014

Keywords

  • BAROREFLEX ACTIVATION THERAPY
  • QUALITY-OF-LIFE
  • CHRONIC HEART-FAILURE
  • RANDOMIZED CONTROLLED-TRIAL
  • BLOOD-PRESSURE REDUCTION
  • CARDIAC OUTCOMES TRIAL
  • RHEOS PIVOTAL TRIAL
  • STAGE RENAL-DISEASE
  • MYOCARDIAL-INFARCTION
  • CARDIOVASCULAR-DISEASE

Cite this